Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment.

Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment. Expert Rev Clin Immunol. 2013 Jun;9(6):495-7 Authors: Zhang L, Newberry KJ, Wang M PMID: 23730878 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23730878?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - June 1, 2013 Category: Cancer & Oncology Authors: Zhang L, Newberry KJ, Wang M Tags: Expert Rev Clin Immunol Source Type: research

More News: Cancer & Oncology | Lymphoma | Myeloma